Autoserum-containing bone marrow cell culture system, autoserum-containing bone marrow cell culture method, and method for producing medicinal composition comprising autoserum-containing cultured bone marrow cells as active ingredient

US10563173B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10563173-B2
Application numberUS-201715594991-A
CountryUS
Kind codeB2
Filing dateMay 15, 2017
Priority dateAug 3, 2010
Publication dateFeb 18, 2020
Grant dateFeb 18, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

To provide an autoserum-containing bone marrow cell culture system, whereby bone marrow cells, which are collected from a subject without using an anticoagulant, are subjected to an anticoagulation treatment using a medium in a liquid-tight state, cultured and then further cultured using the serum of said subject which is prepared in a liquid-tight state; an autoserum-containing bone marrow cell culture method; and a method for producing a medicinal composition which comprises, as the active ingredient, autoserum-containing cultured bone marrow cells. [Solution] An autoserum-containing bone marrow cell culture system for culturing bone marrow cells, which are collected from a subject without using an anticoagulant, using the serum of said subject, said system comprising a bone marrow cell suspension-storing device, a collected blood-storing device, an autoserum-acquiring device, and a bone marrow cell-culturing device.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing cultured bone marrow cells from a subject without use of an anticoagulant, comprising: (a) collecting at a site of the subject a bone marrow fluid in a liquid-tight state without use of an anticoagulant, wherein the collected bone marrow fluid comprises bone marrow cells; (b) mixing the collected bone marrow fluid with a batch of a first culture medium in a liquid-tight state at the site of collection without use of an anticoagulant immediately after step (a), wherein the batch of the first culture medium is in an amount 1.5 times to 6 times the amount of the collected bone marrow fluid, whereby an anticoagulated bone marrow cell suspension comprising the bone marrow cells in the presence of the batch of the first culture medium is prepared; (c) transporting the anticoagulated bone marrow cell suspension in a suspended state to a location of cell culture; and (d) culturing the bone marrow cells in the presence, of the batch of the first culture medium used in step (b) in a bone marrow cell culture vessel at the location of cell culture, whereby the cultured bone marrow cells are prepared. 2. The method of claim 1 , wherein the culturing step is performed in the presence of a serum of the subject. 3. The method of claim 1 , wherein the culturing step is performed in the presence of a serum of the subject and a second culture medium. 4. The method of claim 1 , further comprising: (e) preparing a culture supernatant comprising floating cells from the culture of step (d); (f) removing the culture supernatant from the bone marrow cell culture vessel to produce bone marrow cells attached to the bone marrow cell culture vessel; and (g) adding a medium to the attached bone marrow cells, wherein the medium comprises a serum of the subject. 5. A method for producing a medicinal composition comprising, mixing the cultured bone marrow cells from a subject prepared according to the method of claim 1 with a medium, wherein the medium comprises a serum of the subject. 6. A method for preparing cultured bone marrow cells from a subject without use of an anticoagulant, comprising: (a) collecting at a site of the subject a bone marrow fluid containing bone marrow cells in a liquid-tight state, wherein the collected bone marrow fluid comprises bone marrow cells; (b) mixing the collected bone marrow fluid with a batch of a first culture medium in a liquid-tight state at the site of collection, wherein the batch of the first culture medium is in an amount 1.5 times to 6 times the amount of the collected bone marrow fluid, whereby an anticoagulated bone marrow cell suspension comprising the bone marrow cells in the presence of the batch of the first culture medium is prepared; (c) directly culturing and transporting the bone marrow cells in the anticoagulated bone marrow cell suspension in a suspended state to a location of cell culture, wherein the bone marrow cells are directly cultured in the presence of the batch of the first culture medium used in step (b); and (d) culturing the bone marrow cells from the anticoagulated bone marrow cell suspension from step (c) in a bone marrow cell culture vessel at the location of cell culture, wherein the bone marrow cells are cultured in the presence of the batch of the first culture medium used in steps (b) and (c), whereby the cultured bone marrow cells are prepared. 7. The method of claim 6 , wherein the culturing step (d) is performed in the presence of a serum of the subject. 8. The method of claim 6 , wherein the culturing step (d) is performed in the presence of a serum of the subject and a second culture medium. 9. The method of claim 6 , further comprising: (e) preparing a culture supernatant comprising floating cells from the culture of step (d); (f) removing the culture supernatant from the bone marrow cell culture vessel to produce bone marrow cells attached to the bone marrow cell culture vessel; and (g) adding a medium to the attached bone marrow cells, wherein the medium comprises a serum of the subject. 10. A method for producing a medicinal composition comprising, mixing the cultured bone marrow cells from a subject prepared according to the method of claim 6 with a medium, wherein the medium comprises a serum of the subject.

Assignees

Inventors

Classifications

  • A61K35/28Primary

    Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells · CPC title

  • Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging · CPC title

  • Bone-marrow · CPC title

  • C12N5/0663Primary

    Bone marrow mesenchymal stem cells (BM-MSC) · CPC title

  • being part of container · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10563173B2 cover?
To provide an autoserum-containing bone marrow cell culture system, whereby bone marrow cells, which are collected from a subject without using an anticoagulant, are subjected to an anticoagulation treatment using a medium in a liquid-tight state, cultured and then further cultured using the serum of said subject which is prepared in a liquid-tight state; an autoserum-containing bone marrow cel…
Who is the assignee on this patent?
Univ Sapporo Medical, Nipro Corp
What technology area does this patent fall under?
Primary CPC classification A61K35/28. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).